Avalyn Pharma

Boston, MA · Founded 2011 · In IPO Registration

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases… Avalyn Pharma is based in Boston, MA and was founded in 2011. It is valued at about $155 million as of Oct 2026, set by institutional fund marks. It has raised $387 million.

PMV mark · valuation

$155.0M

Oct 2026

Priced at

—

Total raised

$386.7M

Last round

—

How much has Avalyn Pharma raised?

$386.7Macross 0 recorded rounds

Free account

More of Avalyn Pharma with a free account

·The complete investor list: 28 names
·Watch Avalyn Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Avalyn Pharma investors

28 investors are on record for Avalyn Pharma, including F-Prime Capital, Norwest, Eight Roads and Novo Holdings. By type, the record holds 4 hedge funds, 3 venture capital firms and 2 asset managers.

For fundraisers

Raising for a company like Avalyn Pharma?

28 investors have backed Avalyn Pharma.

See all 28 investors →

Frequently asked about Avalyn Pharma

How much has Avalyn Pharma raised?: Avalyn Pharma has raised $386.7M in total across 0 recorded funding rounds.